Hepatoprotective effect of dipeptidyl peptidase-4 inhibitor sitagliptin against carbon tetrachloride-induced liver fibrosis in mice
Background and Aim Sitagliptin is a selective dipeptidyl peptidase-4 inhibitor that is used worldwide to ameliorate hyperglycemia and insulin insensitivity-induced dysmetabolism. The current study assessed the effect of sitagliptin as well as silymarin (the standard hepatoprotective drug) against ex...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Al-Azhar Assiut Medical Journal |
| Subjects: | |
| Online Access: | http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2021;volume=19;issue=3;spage=459;epage=468;aulast=Ahmed |